Cargando…

P1456: MULTIPARAMETRIC CMR AND CARDIAC COMPLICATIONS IN THALASSEMIA INTERMEDIA

Detalles Bibliográficos
Autores principales:	Meloni, Antonella, Pistoia, Laura, Acquafredda, Amalia, Giovangrossi, Piera, Tedesco, Letizia, Barone, Angelica, Bagnato, Sabrina, Renne, Stefania, Fina, Priscilla, Peritore, Giuseppe, Positano, Vincenzo, Cademartiri, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430426/ http://dx.doi.org/10.1097/01.HS9.0000972708.62302.5d

Ejemplares similares

Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance
por: Meloni, Antonella, et al.
Publicado: (2023)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study
por: Meloni, Antonella, et al.
Publicado: (2021)

P1457: MOTION ABNORMALITIES IN THE LEFT VENTRICLE OF THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

P1454: CLINICAL DETERMINANTS OF CARDIAC IRON IN REGULARLY TRANSFUSED THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

P1515: IMPACT OF GENOTYPE ON PANCREATIC IRON OVERLOAD AND IMPAIRED GLUCOSE METABOLISM IN THALASSEMIA MAJOR
por: Meloni, A., et al.
Publicado: (2022)

P1512: HEART FAILURE IN THALASSEMIA MAJOR: TIME FOR NEW CARDIOVASCULAR MAGNETIC RESONCE MARKERS?
por: Meloni, A., et al.
Publicado: (2022)

Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
por: Meloni, Antonella, et al.
Publicado: (2022)

Pancreatic T2* Magnetic Resonance Imaging for Prediction of Cardiac Arrhythmias in Transfusion-Dependent Thalassemia
por: Meloni, Antonella, et al.
Publicado: (2023)

P1514: MULTI-PARAMETRIC CARDIAC MAGNETIC RESONANCE FOR RISK PREDICTION OF HEART FAILURE DEATH IN THALASSEMIA MAJOR
por: Meloni, A., et al.
Publicado: (2022)

Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2023)

Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy
por: Meloni, Antonella, et al.
Publicado: (2022)

Significant improvement of survival by T2* CMR in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2016)

Left ventricular global function index and left ventricular mass volume ratio by CMR: relation with heart failure in Thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2015)

Thalassemia Intermedia: Chelator or Not?
por: Lee, Yen-Chien, et al.
Publicado: (2022)

Reference ranges for biventricular volumes and ejection fraction and for left ventricular mass in adult thalassemia intermedia patients without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2013)

Myocardial fibrosis by CMR LGE in a large cohrt of pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Endocrine Function in Thalassemia Intermedia
por: Karamifar, H., et al.
Publicado: (2006)

Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major
por: Meloni, Antonella, et al.
Publicado: (2023)

P1513: LOW VITAMIN D LEVELS ARE ASSOCIATED WITH INCREASED CARDIAC IRON UPTAKE IN THALASSEMIA MAJOR.
por: Meloni, A., et al.
Publicado: (2022)

T2* heterogeneity detected by CMR could be related to myocardial iron distribution in Thalassemia patients
por: Positano, Vincenzo, et al.
Publicado: (2009)

PB2533: FREQUENCY, PATTERN, AND CLINICAL CORRELATES OF RENAL IRON ACCUMULATION IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

P1459: CHRONIC HEPATITIS C VIRUS INFECTION IS ASSOCIATED WITH AN INCREASED RISK OF CARDIAC COMPLICATIONS IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox
por: Meloni, Antonella, et al.
Publicado: (2015)

A prospective MRI study of left ventricular iron and function in non-trasfusion-dependent thalassemia intermedia patients treated with desferrioxamine
por: Meloni, Antonella, et al.
Publicado: (2015)

Gender Differences in Knowledge and Perception of Cardiovascular Disease among Italian Thalassemia Major Patients
por: Meloni, Antonella, et al.
Publicado: (2022)

Did the Proband Have Thalassemia Intermedia or Severe Thalassemia Trait?
por: Özsoylu, Şinasi
Publicado: (2012)

Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience
por: Meloni, Antonella, et al.
Publicado: (2023)

Evaluation of Cardiac Function in Patients with Thalassemia Intermedia
por: Nouri, NM, et al.
Publicado: (2013)

Secondary Haemochromatosis in a Patient with Thalassemia Intermedia
por: ROTARU, IONELA, et al.
Publicado: (2014)

Protein C and S levels in patients with Thalassemia intermedia
por: Mohammed, Nawsherwan Sadiq
Publicado: (2022)

Left Ventricular Volumes, Mass and Function normalized to the body surface area, age and gender from CMR in a large cohort of well-treated Thalassemia Major patients without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2011)

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea
por: Zekavat, Omid Reza, et al.
Publicado: (2014)

β-Thalassemia Intermedia: A Bird’s-Eye View
por: Haddad, Anthony, et al.
Publicado: (2014)

Echocardiographic evaluation of thalassemia intermedia patients in Duhok, Iraq
por: Mohammad, Ameen Mosa
Publicado: (2014)

Tophaceous gout in thalassemia intermedia: a rare association
por: Mishra, Vikas, et al.
Publicado: (2016)

Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?
por: Komninaka, Veroniki, et al.
Publicado: (2023)

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014)

Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq
por: Amin, Shaema Salih, et al.
Publicado: (2020)

Frequency of Cholelithiasis in Patients With Beta-Thalassemia Intermedia With and Without Hydroxyurea
por: Khavari, Maryam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s7d1hlvvq7fu8feokbpljnudbp